Paillot Romain
Animal Health Trust, Centre for Preventive Medicine, Lanwades Park, Newmarket, Suffolk CB8 7UU, UK.
Vaccines (Basel). 2014 Nov 14;2(4):797-831. doi: 10.3390/vaccines2040797.
Equine influenza (EI) is a major respiratory disease of horses, which is still causing substantial outbreaks worldwide despite several decades of surveillance and prevention. Alongside quarantine procedures, vaccination is widely used to prevent or limit spread of the disease. The panel of EI vaccines commercially available is probably one of the most varied, including whole inactivated virus vaccines, Immuno-Stimulating Complex adjuvanted vaccines (ISCOM and ISCOM-Matrix), a live attenuated equine influenza virus (EIV) vaccine and a recombinant poxvirus-vectored vaccine. Several other strategies of vaccination are also evaluated. This systematic review reports the advances of EI vaccines during the last few years as well as some of the mechanisms behind the inefficient or sub-optimal response of horses to vaccination.
马流感(EI)是马匹的一种主要呼吸道疾病,尽管经过数十年的监测和预防,仍在全球范围内引发大量疫情。除检疫程序外,疫苗接种被广泛用于预防或限制疾病传播。市面上可获得的EI疫苗种类可能是最多样化的之一,包括全病毒灭活疫苗、免疫刺激复合物佐剂疫苗(免疫刺激复合物和免疫刺激复合物基质)、一种减毒活马流感病毒(EIV)疫苗和一种重组痘病毒载体疫苗。其他几种疫苗接种策略也在评估中。本系统综述报告了过去几年EI疫苗的进展以及马匹对疫苗接种反应低效或不理想背后的一些机制。